About
Bruce Wendel served as Vice Chairman and Chief Executive Officer of Abraxis BioScience until October 15, 2010, when Abraxis was acquired by ...
Companies (1)
Verastem Oncology
View →Advisor
IPO130Needham, Massachusetts, United StatesBiopharma · Biotechnology
People at Verastem Oncology
Alison Lawton
Advisor
Brian Stuglik
Advisor
Dan Calkins
Chief Financial Officer
Daniel Paterson
Board of Director
Jonathan Pachter
Chief Scientific Officer
Michael Kauffman
President of Development
Data from: crunchbase